ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Matinas Biopharma Holdings Inc

Matinas Biopharma Holdings Inc (MTNB)

0,518
-0,012
( -2,26% )
Mis à jour : 18:20:38

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
0,518
Prix Achat
-
Prix Vente
-
Volume échangé
35 900
0,51 Fourchette du Jour 0,525
0,50 Plage de 52 semaines 21,50
Cap du marché
Clôture Veille
0,53
Ouverture
0,51
Dernière Transaction
60
@
0.5171
Dernière heure de transaction
18:11:50
Volume financier
US$ 18 573
VWAP
0,517345
Volume moyen (3 m)
233 481
Actions en circulation
5 086 985
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,11
Bénéfice par action (BPA)
-4,51
Chiffre d'affairess
1,1M
Bénéfice net
-22,94M

À propos de Matinas Biopharma Holdings Inc

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of product candidates derived from its lipid-crystal nano-particle, or cochleate, delivery technology platform. The firm's pipeline includes MAT2203, MAT2501 and others. Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of product candidates derived from its lipid-crystal nano-particle, or cochleate, delivery technology platform. The firm's pipeline includes MAT2203, MAT2501 and others.

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Siège social
Wilmington, Delaware, USA
Fondé
-
Matinas Biopharma Holdings Inc est coté dans le secteur Pharmaceutical Preparations de la American Stock Exchange avec le ticker MTNB. Le dernier cours de clôture d'Matinas Biopharma était de US$0,53. Au cours de la dernière année, les actions de Matinas Biopharma ont été négociées dans une fourchette de prix de US$ 0,50 à US$ 21,50.

Matinas Biopharma compte actuellement 5 086 985 actions en circulation. La capitalisation boursière d'Matinas Biopharma est de US$2,70 million. Matinas Biopharma a un ratio cours/bénéfice (ratio PE) de -0.11.

MTNB Dernières nouvelles

Matinas BioPharma Announces the Termination of MAT2203 Partnership Negotiations and Implements Immediate Workforce Reduction

BEDMINSTER, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) announces that negotiations under the previously disclosed non-binding term sheet...

Matinas BioPharma Reports Second Quarter 2024 Financial Results and Provides a Business Update

Signs non-binding term sheet granting global rights to develop and commercialize oral MAT2203 for invasive aspergillosis and potentially other invasive fungal infections 31 patients have enrolled...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.059-10.22530329290.5770.59230.51523470.53707444CS
4-0.142-21.51515151520.660.6650.51784870.57612373CS
12-2.582-83.29032258063.14.250.52334810.83581207CS
26-7.462-93.50877192987.989.60.55602865.7450334CS
52-9.557-94.85856079410.07521.50.59262199.78935275CS
156-51.482-99.003846153852530.5137441122.30086852CS
260-87.982-99.414689265588.5124.50.5182804740.74905114CS

MTNB - Frequently Asked Questions (FAQ)

What is the current Matinas Biopharma share price?
The current share price of Matinas Biopharma is US$ 0,518
How many Matinas Biopharma shares are in issue?
Matinas Biopharma has 5 086 985 shares in issue
What is the market cap of Matinas Biopharma?
The market capitalisation of Matinas Biopharma is USD 2,7M
What is the 1 year trading range for Matinas Biopharma share price?
Matinas Biopharma has traded in the range of US$ 0,50 to US$ 21,50 during the past year
What is the PE ratio of Matinas Biopharma?
The price to earnings ratio of Matinas Biopharma is -0,11
What is the cash to sales ratio of Matinas Biopharma?
The cash to sales ratio of Matinas Biopharma is 2,37
What is the reporting currency for Matinas Biopharma?
Matinas Biopharma reports financial results in USD
What is the latest annual turnover for Matinas Biopharma?
The latest annual turnover of Matinas Biopharma is USD 1,1M
What is the latest annual profit for Matinas Biopharma?
The latest annual profit of Matinas Biopharma is USD -22,94M
What is the registered address of Matinas Biopharma?
The registered address for Matinas Biopharma is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Matinas Biopharma website address?
The website address for Matinas Biopharma is www.matinasbiopharma.com
Which industry sector does Matinas Biopharma operate in?
Matinas Biopharma operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
CTMCastellum Inc
US$ 1,01
(74,14%)
27,1M
RYDERyde Group Ltd
US$ 0,41
(32,26%)
20,29M
OPTTOcean Power Technologies Inc
US$ 0,4235
(28,84%)
46,16M
ITPIT Tech Packaging Inc
US$ 0,282
(28,18%)
2,57M
KULRKULR Technology Group Inc
US$ 4,245
(24,12%)
76,55M
BTOPBitwise Trendwise BTC ETH and Treasuries Rotation Strategy ETF
US$ 35,04
(-38,06%)
3,19k
BITCBitwise Trendwise Bitcoin and Treasuries Rotation Strategy ETF
US$ 47,4487
(-29,87%)
13,41k
AETHBitwise Trendwise Ether and Treasuries Rotation Strategy ETF
US$ 37,05
(-12,78%)
2,98k
TOVXTheriva Biologics Inc
US$ 1,588
(-9,77%)
667k
ETHU2x Ether ETF
US$ 7,86
(-9,71%)
13,65M
KULRKULR Technology Group Inc
US$ 4,2452
(24,13%)
76,82M
OPTTOcean Power Technologies Inc
US$ 0,4105
(24,89%)
47,15M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
US$ 1,9789
(-0,31%)
36,31M
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 31,015
(1,76%)
29,06M
CTMCastellum Inc
US$ 0,9885
(70,43%)
27,7M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock